EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
SRTA
Strata Critical Medical, Inc.
SRTA lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SRTA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
SRTA's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
SRTA PE Valuation
SRTA has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 100x next year's earnings.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SRTA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SRTA to return to profit, with revenue growing.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
SRTA has the stronger earnings trend. Trailing diluted EPS is down 224% for EOSE versus SRTA down 158%.
SRTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.06 | — |
| Q3 2026 | -$0.29 | -158% |
| Q2 2026 | $0.50 | +$0.73 |
| Q1 2026 | $0.57 | +$0.90 |
| Q4 2025 | $0.50 | +$0.85 |
| Q3 2025 | $0.50 | +$1.19 |
| Q2 2025 | -$0.23 | +$0.43 |
| Q1 2025 | -$0.33 | +$0.35 |
| Q4 2024 | -$0.35 | +$0.41 |
SRTA has swung to a loss: it lost $0.29 per share over the past year, after a profit the year before.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over SRTA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
SRTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $74.1M | +50% |
| Q2 2026 | $72.5M | +2.4% |
| Q1 2026 | $67.4M | +24% |
| Q4 2025 | $66.8M | +23% |
| Q3 2025 | $49.3M | -34% |
| Q2 2025 | $70.8M | +4.2% |
| Q1 2025 | $54.3M | +5.4% |
| Q4 2024 | $54.4M | +14% |
SRTA's revenue has grown year over year for four quarters in a row: $74M last quarter, up 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.2% | +6.2 points |
| Q2 2026 | -7.5% | -0.5 points |
| Q1 2026 | -4.4% | +9.6 points |
| Q4 2025 | -9.6% | +5.8 points |
| Q3 2025 | -11% | -6.7 points |
| Q2 2025 | -7% | +11 points |
| Q1 2025 | -14% | +5.2 points |
| Q4 2024 | -15% | +60 points |
SRTA has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
SRTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.1M | +$49.2M |
| Q2 2026 | $3.2M | +$8.6M |
| Q1 2026 | -$1.3M | +$1.6M |
| Q4 2025 | -$10.2M | -$3.8M |
| Q3 2025 | -$40.1M | -$37.2M |
| Q2 2025 | -$5.4M | +$2.4M |
| Q1 2025 | -$2.9M | +$13.5M |
| Q4 2024 | -$6.3M | +$3M |
SRTA has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
SRTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.4% | +2.1M shares |
| 1 year | +7.1% | +5.8M shares |
| 3 years | +9% | +7.3M shares |
| 5 years | +71% | +36.7M shares |
| Available history | +977% | +80.1M shares |
SRTA has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2019 | — |
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SRTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -10.7x | Net Cash |
SRTA has more cash than debt.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SRTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.4 | Neutral |
| Stochastic | 49.4 | Neutral |
SRTA's weekly RSI is 57 (neutral) and its Stochastic is 49 (neutral).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
SRTA PE vs Industrials Sector
| Metric | SRTA | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 24x | 63% below |
| PE % | 20 | 58 | 38 pts below |
SRTA has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
SRTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.95 | 17% above |
| 20 week MA | $5.25 | 9.9% above |
| 50 week MA | $5.11 | 13% above |
| 100 week MA | $4.53 | 27% above |
| 200 week MA | $3.94 | 46% above |
SRTA has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
SRTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.83 | $11.0 | +12% |
| 2021 | $11.0 | $9.25 | -16% |
| 2022 | $9.25 | $3.50 | -62% |
| 2023 | $3.50 | $3.53 | +0.9% |
| 2024 | $3.53 | $4.41 | +25% |
| 2025 | $4.41 | $4.87 | +10% |
| 2026 YTD | $4.87 | $5.77 | +18% |
SRTA has the edge over EOSE on returns for 2026, with the stronger performance.